Therefore, observations made from both mouse models (Lal–/– and tumor-bearing) and human cancer patients support a notion that LAL plays a suppressive role in these oncogenic processes and can be used for cancer immunotherapy purposes. This evidence concerns the gene LIPA and cancer.